Antaros Medical presents First-in-class PET tracer for the glucagon receptor at EASD 2017

Antaros Medical, in collaboration with Sanofi, presents important data at the 53rd Annual Meeting of the European Association for the study of diabetes (EASD) on a first-in-class Glucagon (GCG) Positron Emission Tomography (PET) ligand, with suitable properties for clinical development targeting the glucagon receptor.

In addition, Antaros founders contribute to science at EASD 2017 in three additional poster:

Pereira MJ, Skrtic A, Katsogiannos P,  Abrahamsson N, Kullberg J, Nowak C, Eriksson JW

Boersma GJ, Heurling K, Pereira MJ, Johansson E, Lubberink M, B
örjesson JL, Katsogiannos P, Skrtic S, Kullberg J, Ahlström H, Eriksson JW

Hyypia A, Makine J, Oscarsson J, Hannukainen J, Kullberg J, Johansson L, Nuutila P, Miikka-Juhani Honka MJ

Pressify Share on Linkedin Share on Twitter